Mono- and Disubstituted-3,8-diazabicyclo[3.2.1]octane Derivatives as Analgesics Structurally Related to Epibatidine: Synthesis, Activity, and Modeling
Authors:
- Giorgio CignarellaGCGiorgio Cignarella
- Donatella TondiDonatella Tondi
- Paola VianelloPVPaola Vianello
- Stefania VillaStefania Villa
- Alessandro BartoliniABAlessandro Bartolini
- Carla GhelardiniCGCarla Ghelardini
- Nicoletta GaleottiNicoletta Galeotti
- David J. AndersonDADavid J. Anderson
- Theresa A. KuntzweilerTKTheresa A. Kuntzweiler
- Diego ColomboDCDiego Colombo
- Lucio TomaLTLucio Toma
- 30 January 1998
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 41 (5) , 674-681
Abstract
A series of 3,8-diazabicyclo[3.2.1]octanes substituted either at the 3 position (compounds 1) or at the 8 position (compounds 2) by a chlorinated heteroaryl ring were synthesized, as potential analogues of the potent natural analgesic epibatidine. When tested in the hot plate assay, the majority of the compounds showed significant effects, the most interesting being the 3-(6-chloro-3-pyridazinyl)-3,8-diazabicyclo[3.2.1]octane (1a). At a subcutaneous dose of 1 mg/kg, 1a induced a significant increase in the pain threshold, its action lasting for about 45 min. 1a also demonstrated good protection at a dose of 5 mg/kg in the mouse abdominal constriction test, while at 20 mg/kg it completely prevented the constrictions in the animals. Administration of naloxone (1 mg/kg ip) did not antagonize its antinociception while mecamylamine (2 mg/kg ip) did, thus suggesting the involvement of the nicotinic system in its action. Binding studies confirmed high affinity for the α4β2 nAChR subtype (Ki = 4.1 ± 0.21 nM). nAChR functional activity studies on three different cell lines showed that 1a was devoid of any activity at the neuromuscular junction. Finally, due to the analogy in their pharmacological profile with that of epibatidine, compounds were compared from a structural and conformational point of view through theoretical calculations and high-field 1H NMR spectroscopy. Results indicate that all of them present one conformation similar to that of epibatidine.Keywords
This publication has 10 references indexed in Scilit:
- Antinociceptive profile of the new nicotinic agonist DBO-83Drug Development Research, 1997
- Epibatidine: Pharmacological Properties of a Novel Nicotinic Acetylcholine Receptor Agonist and Analgesic AgentCNS Drug Reviews, 1996
- Epibatidine: a novel (chloropyridyl)azabicycloheptane with potent analgesic activity from an Ecuadoran poison frogJournal of the American Chemical Society, 1992
- Interaction of 3,8-diazabicyclo (3.2.1) octanes with mu and delta opioid receptorsPharmacological Research Communications, 1988
- Characterization of Curaremimetic Neurotoxin Binding Sites on Membrane Fractions Derived from the Human Medulloblastoma Clonal Line, TE671Journal of Neurochemistry, 1986
- A comparison of the antinociceptive responses to the GABA-receptor agonists THIP and baclofenNeuropharmacology, 1985
- Thermal and chemical intramolecular N → N acyl-migration in 8-acyl-3, 8-diazabicyclo[3.2.1]octanesTetrahedron, 1963
- The Synthesis of 3,8-Diazabicyclo[3.2.1]octane and Some of Its N-Substituted DerivativesThe Journal of Organic Chemistry, 1961
- PHARMACOLOGICAL EFFECTS PRODUCED BY INTRACEREBRAL INJECTION OF DRUGS IN THE CONSCIOUS MOUSEBritish Journal of Pharmacology and Chemotherapy, 1957
- Heilmittelchemische Studien in der heterocyclischen Reihe. 4. Mitteilung. Pyridazine I. Derivate des cyclischen Maleinsäure‐ und Citraconsäure‐hydrazidsHelvetica Chimica Acta, 1954